Suppr超能文献

利用分子对接和分子动力学设计抗口疮病毒的多表位亚单位疫苗。

Designing a multi-epitope subunit vaccine against Orf virus using molecular docking and molecular dynamics.

机构信息

Department of Veterinary Medicine, College of Animal Science, Guizhou University, Guiyang, China.

出版信息

Virulence. 2024 Dec;15(1):2398171. doi: 10.1080/21505594.2024.2398171. Epub 2024 Sep 11.

Abstract

Orf virus (ORFV) is an acute contact, epitheliotropic, zoonotic, and double-stranded DNA virus that causes significant economic losses in the livestock industry. The objective of this study is to design an immunoinformatics-based multi-epitope subunit vaccine against ORFV. Various immunodominant cytotoxic T lymphocytes (CTL), helper T lymphocytes (HTL), and B-cell epitopes from the B2L, F1L, and 080 protein of ORFV were selected and linked by short connectors to construct a multi-epitope subunit vaccine. Immunogenicity was enhanced by adding an adjuvant β-defensin to the N-terminal of the vaccine using the EAAAK linker. The vaccine exhibited a significant degree of antigenicity and solubility, without allergenicity or toxicity. The 3D formation of the vaccine was subsequently anticipated, improved, and verified. The optimized model exhibited a lower Z-score of -4.33, indicating higher quality. Molecular docking results demonstrated that the vaccine strongly binds to TLR2 and TLR4. Molecular dynamics results indicated that the docked vaccine-TLR complexes were stable. Immune simulation analyses further confirmed that the vaccine can induce a marked increase in IgG and IgM antibody titers, and elevated levels of IFN-γ and IL-2. Finally, the optimized DNA sequence of the vaccine was cloned into the vector pET28a (+) for high expression in the expression system. Overall, the designed multi-epitope subunit vaccine is highly stable and can induce robust humoral and cellular immunity, making it a promising vaccine candidate against ORFV.

摘要

口疮病毒(ORFV)是一种急性接触性、上皮嗜性、人畜共患的双链 DNA 病毒,它会给畜牧业造成重大的经济损失。本研究旨在设计一种基于免疫信息学的 ORFV 多表位亚单位疫苗。从 ORFV 的 B2L、F1L 和 080 蛋白中选择了多种免疫显性细胞毒性 T 淋巴细胞(CTL)、辅助性 T 淋巴细胞(HTL)和 B 细胞表位,并通过短接头将其连接起来构建多表位亚单位疫苗。通过在疫苗的 N 端添加一个佐剂β-防御素,使用 EAAAK 接头来增强其免疫原性。该疫苗表现出显著的抗原性和可溶性,没有变应原性或毒性。随后预测、改进和验证了疫苗的 3D 形成。优化后的模型显示出较低的 Z 分数-4.33,表明质量更高。分子对接结果表明,疫苗与 TLR2 和 TLR4 结合牢固。分子动力学结果表明,对接的疫苗-TLR 复合物稳定。免疫模拟分析进一步证实,疫苗可以引起 IgG 和 IgM 抗体滴度的显著增加,以及 IFN-γ 和 IL-2 水平的升高。最后,将疫苗的优化 DNA 序列克隆到载体 pET28a(+)中,在表达系统中进行高效表达。总的来说,设计的多表位亚单位疫苗高度稳定,可以诱导强烈的体液和细胞免疫,是一种有前途的 ORFV 疫苗候选物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验